| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/27/2004 | US6727254 8-(bis-(phenyl) methyl)-3-heteroaryl-8-azabicyclo-(3.2.1)octan-3-ols and derivatives, useful in treating pain, anxiety, cough, asthma, depresion and alcohol abuse |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders |
| 04/27/2004 | US6727245 Heterobicyclic derivatives |
| 04/27/2004 | US6727227 Cause an increase in superoxide dismutase activity in said subject |
| 04/27/2004 | CA2296244C Adjuvants for use in vaccines |
| 04/22/2004 | WO2004033498A2 .pharmaceutical composition comprising ht4d100a receptors, and therapeutic uses thereof |
| 04/22/2004 | WO2004033463A1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES |
| 04/22/2004 | WO2004033412A1 Novel beta mimetics with extended duration of action, method for production and use thereof as medicaments |
| 04/22/2004 | WO2004032969A1 Modulation of immune function |
| 04/22/2004 | WO2004032964A1 Remedies for allergic diseases |
| 04/22/2004 | WO2004032918A1 Treatment of inflammatory conditions with ∝-3 polyunsaturated fatty acids |
| 04/22/2004 | WO2004032843A2 Mucoadhesive tetracycline formulations |
| 04/22/2004 | WO2004020430A3 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/22/2004 | WO2004018431A3 Novel phenanthridines |
| 04/22/2004 | WO2004017948A3 Use of lck inhibitor for treatment of immunologic diseases |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2004009784A3 Novel inhibitors of kinases |
| 04/22/2004 | WO2004005310A3 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 04/22/2004 | WO2004005243A3 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 04/22/2004 | WO2003105907A3 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
| 04/22/2004 | WO2003084476A3 Treatment of lung disorder |
| 04/22/2004 | WO2003063842A9 Composition for inhalation |
| 04/22/2004 | WO2003057722A3 Cyclic tetrapeptide compound and use thereof |
| 04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
| 04/22/2004 | WO2003005999A8 Methods of treating cytokine mediated diseases |
| 04/22/2004 | WO2002092017A8 Human antipneumococcal antibodies from non-human animals |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002011711B1 Formulations of mometasone and a bronchodilator for pulmonary administration |
| 04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
| 04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
| 04/22/2004 | US20040077854 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 04/22/2004 | US20040077717 Method of treating neutrophil-related diseases with topical anesthetics |
| 04/22/2004 | US20040077704 Fused cyclopenta-, cyclohexa-, or cyclohepta(g)indole derivatives as human non-pancreatic secretory phospholipase inhibitors; antiinflammatory agents |
| 04/22/2004 | US20040077695 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077680 Ureaacylated indazole, benzisoxazole, or benzisothiazole derivative with monocyte chemoattractant protein inhibitors; antiinflammatory agents; autoimmune diseases; arthritis, asthma, atherosclerosis, diabetes |
| 04/22/2004 | US20040077678 Urea substituted imidazoquinoline ethers |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077665 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 04/22/2004 | US20040077664 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 04/22/2004 | US20040077658 Respiratory system, nervous system, brain, gastrointestinal and psychological disorders; chronic obstructive pulmonary disease; antiasthmatics, analgesics |
| 04/22/2004 | US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 04/22/2004 | US20040077639 Administering amidine derivative as antiasthmatic agents; chronic obstructive pulmonary disease treatment |
| 04/22/2004 | US20040077632 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/22/2004 | US20040077629 Such as 4-methyl-2-hydroxy-2-(4-hydroxy-4-methylpentyl)-butanediocate ester cephalotaxine derivative |
| 04/22/2004 | US20040077612 Acting as prodrugs; higher concentration delivery of active material to target cell in hybrid form; decreasing side effects |
| 04/22/2004 | US20040077552 Inflammation-inhibiting compounds |
| 04/22/2004 | US20040076986 A gene and/or a protein involved in the prevention or treatment of allergic diseases and dermatitis |
| 04/22/2004 | US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection, |
| 04/22/2004 | US20040076956 Oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence; ascertaining genetic and/ or epigenetic parameters of DNA repair genes |
| 04/22/2004 | US20040076697 Pressing plant roots or stems, then purification of the liquids, mixing ethanol, storing in refrigerators and filtering, to obtain plant extracts used for prophylaxis of respiratory system disorders; solvent extraction |
| 04/22/2004 | US20040076693 Mixtures of vegetable oils and optionally solubilizers, used for prophylaxis of respiratory system disorders and infections |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/22/2004 | US20040076669 Tramadol-based medicament |
| 04/22/2004 | US20040076639 Antiallergens is encoded from Mycobacterium, genetic vaccines, for immunotherapy treating atopic dermatitis, asthma, rhinitis, or conjunctivitis, as immunosuppressants inhibiting the production of interleukin-4 |
| 04/22/2004 | US20040076625 A fusion proteins comprising self or non-self antigens, is used for treatment and prevention of immunoglobulin E related diseases, gene expression |
| 04/22/2004 | US20040076614 For natural cellular immune defense in humans/animals; for foods/feeds |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/22/2004 | CA2501614A1 Mucoadhesive tetracycline formulations |
| 04/22/2004 | CA2501055A1 Novel betamimetics with extended duration of action, method for production and use thereof as medicaments |
| 04/21/2004 | EP1411128A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 04/21/2004 | EP1410822A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 04/21/2004 | EP1410802A1 Cell death inducers for mast cells |
| 04/21/2004 | EP1410798A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 04/21/2004 | EP1410796A2 New therapeutic uses for potassium channel openers |
| 04/21/2004 | EP1410040A2 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409740A2 Asthma-associated gene |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409670A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409540A2 Melanocortin receptor ligands |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409503A1 Non-natural carbon-linked nucleotides and dinucleotides |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409485A1 Novel immunomodulating compounds |
| 04/21/2004 | EP1409481A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 04/21/2004 | EP1409477A1 Piperidine derivatives as nmda receptor antagonists |
| 04/21/2004 | EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/21/2004 | EP1409455A1 Prostaglandin analogues-as ep4 receptor agonists |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1408987A2 Tetracycline compounds having target therapeutic activities |
| 04/21/2004 | EP1408984A2 Organo-phosphorous compounds for activating gamma/delta t cells |
| 04/21/2004 | EP1408967A2 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 04/21/2004 | EP1408962A1 Substituted isoindoles and the use thereof |
| 04/21/2004 | EP1408950A2 Methods of treating cytokine mediated diseases |
| 04/21/2004 | EP1408947A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 04/21/2004 | EP1408943A2 Pharmaceutical formulation containing an ltb4 antagonist |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP1267900B1 Emulsion containing a triterpen containing plant extract, method for producing said emulsion and for obtaining a plant extract |
| 04/21/2004 | EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/21/2004 | EP1154987B1 Phenylalaninol derivatives |